Privilege escalation in IBM Maximo Application Suite
CVE-2025-2898
IBM Maximo Application Suite 9.0 could allow an attacker with some level of access to elevate their privileges due to a security configuration vulnerability in Role-Based Access Control (RBAC) configurations.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 7.5 (High). Vector: CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H.
EPSS exploit prediction
EPSS: 0.003 (26.4th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 26th percentile — 26.4% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.003 · newest: 0.003 · change: +0.000
Affected products
- IBM Maximo Application Suite — versions 9.0
- IBM Maximo Application Suite — versions 9.0
Weakness classification (CWE)
References
- https://www.ibm.com/support/pages/node/7232050 (vendor-advisory, patch, Vendor Advisory)
- www.ibm.com/support/pages/node/7232050 (Vendor Advisory)
Frequently asked questions
- What is CVE-2025-2898?
- CVE-2025-2898 is a high-severity vulnerability in IBM Maximo Application Suite, classified under Incorrect Privilege Assignment. CVSS score: 7.5/10. Published 2025-05-06.
- How severe is CVE-2025-2898?
- High severity. CVSS v3 base score is 7.5 out of 10.